Collaboration Agreement with Sanofi IGM Biosciences, Inc. (NASDAQ: IGMS), a biotechnology company leveraging its expertise in Immunoglobulin M (IgM) antibodies, announced an exclusive worldwide collaboration agreement with Sanofi (NASDAQ: SNY). The agreement is for developing and commercializing IgM antibody agonists against six initial targets, three in...
Aligos Therapeutics, Inc. (NASDAQ: ALGS), a clinical-stage biotechnology Company announced the discontinuation of dosing in the first cohort of its candidate ALG-020572, intended for the treatment of chronic hepatitis B. The dosing was stopped after a patient experienced a serious adverse event (SAE) and a...
This week we bring to you four companies, namely Sunworks (NASDAQ: SUNW), Progenity Inc (NASDAQ: PROG), Upland Software Inc (NASDAQ: UPLD) and Purple Innovation Inc (NASDAQ: PRPL) that could turn out be to vulnerable investments, in view of the challenges being faced by these companies, such as...
“Realignment” of Management Team Rafael Holdings, Inc. (NYSE: RFL), announced the realignment of its management team, including the departure of the CEO Ameet Mallik, William Conkling, chief commercial and business officer and Ashok David Marin, chief legal officer among others. The responsibilities of the CEO will...
